substance p has been researched along with chronic COVID syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Primo, C; Dilly, S; Goupil-Lamy, A; Henri, J; Minder, L; Mohanasundaram, K; Slama Schwok, A | 1 |
| Albanese, M; Boffa, L; Bovenzi, R; Di Girolamo, S; Greco, A; Grillo, P; Lattanzi, R; Loccisano, L; Maftei, D; Maurizi, R; Mercuri, NB; Passali, FM; Schirinzi, T; Severini, C; Simonetta, C; Vincenzi, M; Zenuni, H | 1 |
| Karamyan, VT | 1 |
1 review(s) available for substance p and chronic COVID syndrome
| Article | Year |
|---|---|
Between two storms, vasoactive peptides or bradykinin underlie severity of COVID-19?
Topics: Animals; Bradykinin; COVID-19; Cytokines; Humans; Microvessels; Neprilysin; Neurotensin; Post-Acute COVID-19 Syndrome; Substance P | 2021 |
2 other study(ies) available for substance p and chronic COVID syndrome
| Article | Year |
|---|---|
Neuropeptides, New Ligands of SARS-CoV-2 Nucleoprotein, a Potential Link between Replication, Inflammation and Neurotransmission.
Topics: COVID-19; Humans; Inflammation; Ligands; Neuropeptides; Nucleoproteins; Post-Acute COVID-19 Syndrome; SARS-CoV-2; Substance P; Synaptic Transmission | 2022 |
Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction.
Topics: COVID-19; Humans; Neurons; Olfaction Disorders; Post-Acute COVID-19 Syndrome; SARS-CoV-2; Smell; Substance P | 2023 |